Panion & Bf Biotech Inc. (TPE:1760)
49.35
+0.05 (0.10%)
Nov 10, 2026, 1:30 PM CST
Panion & Bf Biotech Market Cap
Panion & Bf Biotech has a market cap or net worth of 4.23 billion as of November 9, 2026. It is the 23,244th most valuable company in the world and the 1,146th biggest in Taiwan. Its market cap has decreased by 22.65% in one year.
Market Cap
4.23B
Enterprise Value
4.39B
Revenue
2.11B
Global Rank
Country Rank
#1,146 Taiwan
PE Ratio
19.74
ChartMarket Cap Chart
Since September 30, 2004, Panion & Bf Biotech's market cap has increased from 534.45M to 4.23B, an increase of 691.69%. That is a compound annual growth rate of 9.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 4.23B | -21.67% |
| Dec 31, 2025 | 5.40B | -23.26% |
| Dec 31, 2024 | 7.04B | -26.70% |
| Dec 29, 2023 | 9.60B | -37.43% |
| Dec 30, 2022 | 15.35B | 138.03% |
| Dec 30, 2021 | 6.45B | -1.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.07B |
| Orient Pharma | 5.48B |
| Formosa Laboratories | 5.38B |
| Alar Pharmaceuticals | 5.11B |
| LIWANLI Innovation | 4.50B |
| Yoda Pharmaceuticals | 3.87B |
| Orient EuroPharma | 3.65B |
| Easywell Biomedicals | 3.10B |